De Paepe Peter, Colin Pieter, Depuydt Pieter, Decavele An-Sofie, De Smet Julie, Boussery Koen, Stove Christophe, Benoit Dominique, Verstraete Alain, Van Bocxlaer Jan, Buylaert Walter
a Department of Emergency Medicine , Ghent University Hospital , Ghent , Belgium.
b Heymans Institute of Pharmacology, Ghent University , Ghent , Belgium.
Clin Toxicol (Phila). 2016;54(1):56-60. doi: 10.3109/15563650.2015.1101770. Epub 2015 Dec 1.
Cyanide poisoning may be caused by acetonitrile, a common industrial organic solvent and laboratory agent.
To describe the potential use of disulfiram in treating acetonitrile poisoning in a human clinical case and to further study its effect in human liver microsomes in vitro.
A 30-year-old man initially presented with a cholinergic toxic syndrome following ingestion of aldicarb. Toxicological analysis revealed coingestion of ethanol. He subsequently developed severe metabolic acidosis caused by the cyanogenic compound acetonitrile which was erroneously interpreted as acetone in the chromatogram. After three treatments with hydroxocobalamin (5 g i.v.) and sodium thiosulfate (12.5 g i.v.) on days 2, 3, and 5, he had transient improvement but recurrent lactic acidosis. Treatment with disulfiram was associated on day 7 with resolution of metabolic acidosis and slowing of the decrease in acetonitrile concentration. He recovered from acetonitrile toxicity completely. The time course of acetonitrile, thiocyanate, and cyanide concentrations suggested that disulfiram inhibited cyanide formation.
In vitro experiments with human liver microsomes showed the cyanide concentration was significantly lower after incubation with acetonitrile and disulfiram than acetonitrile alone (a mean 60% reduction in cyanide level).
Although disulfiram was given late in the course of the poisoning it is possible that it contributed to the recovery.